NEJM Evidence Issues Research Articles in June 2024 Edition
June 08, 2024
June 08, 2024
WALTHAM, Massachusetts, June 8 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its June 2024 edition (Vol. 3, No. 6):
Original Articles:
* Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention
* Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
Original Articles:
* Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention
* Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
